CompChem-Database: compound details

CompChem-Database: details for selected entry

DB07876_p0 (7379)

Formula C₁₆H₂₁N₃O₂S

MW 319.42

InChIKey AWDORCFLUJZUQS-UHFFFAOYNA-N

Entry_Date 2023-09-01

Net_Charge 0

Number_Atoms 43

Number_Heavy_Atoms 22

Number_Rings 3

Number_Bonds 45

Rotat_Bonds 2

Unbranched_Chain 1

Chiral_Centers 1

ONatoms 5

HB_Donor 1

HB_Acceptor 3

OpenEye_HB_Donors 1

OpenEye_HB_Acceptors 4

Lipinski_HB_Donors 1

Lipinski_HB_Acceptors 5

Lipinski_Violations 0

XLogP3 0

XLogP 1.62

logP 3.2632

PSA 70.68

MR 95.2517

ABS 0.55

Solubility very

Aggregator Pass

PM7_Heat_of_Formation_kcal_per_mol -24.285

PM7_Total_Energy_ev -3573.85831

PM7_Electronic_Energy_ev -29068.06124

PM7_Dipole_Debye 3.10352

PM7_Point_Group C1

PM7_HOMO_Energy_ev -9.112

PM7_LUMO_Energy_ev -1.452

PM7_COSMO_Area_square_ang 299.03

PM7_COSMO_Volue_cubic_ang 377.68

PM7_Electron_Affinity_ev 1.452

PM7_Ionization_Energy_ev 9.112

PM7_Energy_Gap_ev 7.66

PM7_Global_Hardness_ev 3.83

PM7_Global_Softness_ev 0.26109660574412535

PM7_Chemical_Potential_ev -5.282

PM7_Electronigativity_ev 5.282

PM7_Back_Donation_Energy_ev -0.9575

PM7_Electrophilicity_ev 3.642235509138381

OPENEYE_Name 4-methyl-5-[[(1~{R},2~{S})-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline

SMILES c1cc2cncc(c2c(c1)S(=O)(=O)N3CCCNCC3C)C

Canonical_SMILES C[C@H]1CNCCCN1S(=O)(=O)c1cccc2c1c(C)cnc2

InChI 1/C16H21N3O2S/c1-12-9-18-11-14-5-3-6-15(16(12)14)22(20,21)19-8-4-7-17-10-13(19)2/h3,5-6,9,11,13,17H,4,7-8,10H2,1-2H3

InChI_3D 1S/C16H21N3O2S/c1-12-9-18-11-14-5-3-6-15(16(12)14)22(20,21)19-8-4-7-17-10-13(19)2/h3,5-6,9,11,13,17H,4,7-8,10H2,1-2H3/t13-/m0/s1

AuxInfo 1/0/N:15,16,1,10,2,3,11,12,5,13,4,8,14,6,9,7,18,17,19,20,21,22/E:(20,21)/CRV:22.6/rA:43cCCCCCCCCCCCCCCCCNNNOOSHHHHHHHHHHHHHHHHHHHHH/rB:d1;s1;;;s2d4;s6;s5d7;d3s7;;s10;s10;;s13;s8;s14;s4d5;s11s13;s12s14;;;s9s19d20d21;s1;s2;s3;s4;s5;s10;s10;s11;s11;s12;s12;s13;s13;s14;s15;s15;s15;s16;s16;s16;s18;/rC:0,1.0089,0;.8707,1.5185,0;;2.6125,1.5125,0;3.4805,-.0073,0;1.7414,1.0089,0;1.7371,0,0;2.6039,-.5053,0;.8707,-.4993,0;2.0003,-5.4093,0;1.3732,-6.197,0;1.78,-4.4306,0;-.2559,-5.415,0;-.0327,-4.4338,0;2.5983,-1.5053,0;-1.7827,-4.4334,0;3.4848,1.0014,0;.3732,-6.2012,0;.8744,-3.9993,0;-.1274,-2.2504,0;1.8726,-2.2482,0;.8726,-2.2493,0;-.4338,1.2576,0;.8707,2.0185,0;-.4326,-.2506,0;2.614,2.0125,0;3.9121,-.2597,0;2.3119,-5.8003,0;2.4511,-5.1931,0;1.2634,-6.6848,0;1.8241,-6.4131,0;2.28,-4.4309,0;1.8904,-3.943,0;-.7066,-5.1985,0;-.5671,-5.8063,0;-.1434,-3.9462,0;3.0983,-1.5081,0;2.0983,-1.5025,0;2.5955,-2.0053,0;-1.7826,-3.9334,0;-2.2827,-4.4332,0;-1.7828,-4.9334,0;.1576,-6.6523,0;

Duplicates DB07876_p0

mol2_Path /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000007750-0000007999/DB07876_p0.mol2

pdbqt_Path /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000007750-0000007999/DB07876_p0.pdbqt

sdf_Path /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000007750-0000007999/DB07876_p0.sdf

Formula	C₁₆H₂₁N₃O₂S
MW	319.42
InChIKey	AWDORCFLUJZUQS-UHFFFAOYNA-N
Entry_Date	2023-09-01
Net_Charge	0
Number_Atoms	43
Number_Heavy_Atoms	22
Number_Rings	3
Number_Bonds	45
Rotat_Bonds	2
Unbranched_Chain	1
Chiral_Centers	1
ONatoms	5
HB_Donor	1
HB_Acceptor	3
OpenEye_HB_Donors	1
OpenEye_HB_Acceptors	4
Lipinski_HB_Donors	1
Lipinski_HB_Acceptors	5
Lipinski_Violations	0
XLogP3	0
XLogP	1.62
logP	3.2632
PSA	70.68
MR	95.2517
ABS	0.55
Solubility	very
Aggregator	Pass
PM7_Heat_of_Formation_kcal_per_mol	-24.285
PM7_Total_Energy_ev	-3573.85831
PM7_Electronic_Energy_ev	-29068.06124
PM7_Dipole_Debye	3.10352
PM7_Point_Group	C1
PM7_HOMO_Energy_ev	-9.112
PM7_LUMO_Energy_ev	-1.452
PM7_COSMO_Area_square_ang	299.03
PM7_COSMO_Volue_cubic_ang	377.68
PM7_Electron_Affinity_ev	1.452
PM7_Ionization_Energy_ev	9.112
PM7_Energy_Gap_ev	7.66
PM7_Global_Hardness_ev	3.83
PM7_Global_Softness_ev	0.26109660574412535
PM7_Chemical_Potential_ev	-5.282
PM7_Electronigativity_ev	5.282
PM7_Back_Donation_Energy_ev	-0.9575
PM7_Electrophilicity_ev	3.642235509138381
OPENEYE_Name	4-methyl-5-[[(1~{R},2~{S})-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline
SMILES	c1cc2cncc(c2c(c1)S(=O)(=O)N3CCCNCC3C)C
Canonical_SMILES	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2c1c(C)cnc2
InChI	1/C16H21N3O2S/c1-12-9-18-11-14-5-3-6-15(16(12)14)22(20,21)19-8-4-7-17-10-13(19)2/h3,5-6,9,11,13,17H,4,7-8,10H2,1-2H3
InChI_3D	1S/C16H21N3O2S/c1-12-9-18-11-14-5-3-6-15(16(12)14)22(20,21)19-8-4-7-17-10-13(19)2/h3,5-6,9,11,13,17H,4,7-8,10H2,1-2H3/t13-/m0/s1
AuxInfo	1/0/N:15,16,1,10,2,3,11,12,5,13,4,8,14,6,9,7,18,17,19,20,21,22/E:(20,21)/CRV:22.6/rA:43cCCCCCCCCCCCCCCCCNNNOOSHHHHHHHHHHHHHHHHHHHHH/rB:d1;s1;;;s2d4;s6;s5d7;d3s7;;s10;s10;;s13;s8;s14;s4d5;s11s13;s12s14;;;s9s19d20d21;s1;s2;s3;s4;s5;s10;s10;s11;s11;s12;s12;s13;s13;s14;s15;s15;s15;s16;s16;s16;s18;/rC:0,1.0089,0;.8707,1.5185,0;;2.6125,1.5125,0;3.4805,-.0073,0;1.7414,1.0089,0;1.7371,0,0;2.6039,-.5053,0;.8707,-.4993,0;2.0003,-5.4093,0;1.3732,-6.197,0;1.78,-4.4306,0;-.2559,-5.415,0;-.0327,-4.4338,0;2.5983,-1.5053,0;-1.7827,-4.4334,0;3.4848,1.0014,0;.3732,-6.2012,0;.8744,-3.9993,0;-.1274,-2.2504,0;1.8726,-2.2482,0;.8726,-2.2493,0;-.4338,1.2576,0;.8707,2.0185,0;-.4326,-.2506,0;2.614,2.0125,0;3.9121,-.2597,0;2.3119,-5.8003,0;2.4511,-5.1931,0;1.2634,-6.6848,0;1.8241,-6.4131,0;2.28,-4.4309,0;1.8904,-3.943,0;-.7066,-5.1985,0;-.5671,-5.8063,0;-.1434,-3.9462,0;3.0983,-1.5081,0;2.0983,-1.5025,0;2.5955,-2.0053,0;-1.7826,-3.9334,0;-2.2827,-4.4332,0;-1.7828,-4.9334,0;.1576,-6.6523,0;
Duplicates	DB07876_p0
mol2_Path	/CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000007750-0000007999/DB07876_p0.mol2
pdbqt_Path	/CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000007750-0000007999/DB07876_p0.pdbqt
sdf_Path	/CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000007750-0000007999/DB07876_p0.sdf